• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟与肺癌风险:基于对日本人群流行病学证据的系统评价

Tobacco smoking and lung cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population.

作者信息

Wakai Kenji, Inoue Manami, Mizoue Tetsuya, Tanaka Keitaro, Tsuji Ichiro, Nagata Chisato, Tsugane Shoichiro

机构信息

Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.

出版信息

Jpn J Clin Oncol. 2006 May;36(5):309-24. doi: 10.1093/jjco/hyl025. Epub 2006 May 30.

DOI:10.1093/jjco/hyl025
PMID:16735374
Abstract

BACKGROUND

Although tobacco smoking is the best established risk factor for lung cancer, the association is not as strong among Japanese as among Western populations. It would be of value, therefore, to quantify that association in Japan based on a systematic review of epidemiological evidence for the primary prevention of lung cancer.

METHODS

Original data were obtained from MEDLINE searches using PubMed, supplemented with manual searches. The evaluation of associations was based on the strength of evidence and the magnitude of the association, together with biological plausibility as previously evaluated by the International Agency for Research on Cancer. A meta-analysis was also conducted to estimate the summary measure of those associations.

RESULTS

A total of 8 cohort studies and 14 case-control studies were identified, almost all of which consistently showed a strong association of current smoking with the risk of lung cancer. The summary relative risk for current smokers versus never smokers was estimated as 4.39 (95% confidence interval 3.92-4.92) for men and 2.79 (95% confidence interval 2.44-3.20) for women. Cohort studies and case-control studies gave reasonably consistent summary measures. The summary relative risks were 11.7 and 2.30 for squamous cell carcinoma and adenocarcinoma, respectively, in men, and were 11.3 and 1.37 correspondingly in women.

CONCLUSION

There is convincing evidence that tobacco smoking strongly increases the risk of lung cancer in the Japanese population, with the relative risk for current smokers compared with never smokers measuring around 4.4 for men and 2.8 for women.

摘要

背景

尽管吸烟是肺癌最明确的风险因素,但在日本人群中,这种关联不如在西方人群中那么强烈。因此,基于对肺癌一级预防的流行病学证据进行系统综述,在日本对这种关联进行量化将具有重要意义。

方法

原始数据通过使用PubMed在MEDLINE中检索获得,并辅以手工检索。关联评估基于证据强度、关联程度以及国际癌症研究机构先前评估的生物学合理性。还进行了荟萃分析以估计这些关联的汇总指标。

结果

共识别出8项队列研究和14项病例对照研究,几乎所有研究都一致显示当前吸烟与肺癌风险之间存在强烈关联。男性当前吸烟者与从不吸烟者的汇总相对风险估计为4.39(95%置信区间3.92 - 4.92),女性为2.79(95%置信区间2.44 - 3.20)。队列研究和病例对照研究给出了相当一致的汇总指标。男性鳞状细胞癌和腺癌的汇总相对风险分别为11.7和2.30,女性相应为11.3和1.37。

结论

有令人信服的证据表明,吸烟会显著增加日本人群患肺癌的风险,当前吸烟者与从不吸烟者相比,男性的相对风险约为4.4,女性约为2.8。

相似文献

1
Tobacco smoking and lung cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population.吸烟与肺癌风险:基于对日本人群流行病学证据的系统评价
Jpn J Clin Oncol. 2006 May;36(5):309-24. doi: 10.1093/jjco/hyl025. Epub 2006 May 30.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Heated tobacco products for smoking cessation and reducing smoking prevalence.加热烟草制品戒烟和降低吸烟率。
Cochrane Database Syst Rev. 2022 Jan 6;1(1):CD013790. doi: 10.1002/14651858.CD013790.pub2.
5
Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population.吸烟与乳腺癌风险:基于对日本人群流行病学证据的系统评价
Jpn J Clin Oncol. 2006 Jun;36(6):387-94. doi: 10.1093/jjco/hyl031. Epub 2006 Jun 9.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Alcohol drinking and lung cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population.饮酒与肺癌风险:基于对日本人群流行病学证据的系统评价
Jpn J Clin Oncol. 2007 Mar;37(3):168-74. doi: 10.1093/jjco/hyl146. Epub 2007 Mar 1.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Tobacco cessation interventions for young people.针对年轻人的戒烟干预措施。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD003289. doi: 10.1002/14651858.CD003289.pub4.
10
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.

引用本文的文献

1
Comparative analysis of the toxic effects on the mouse lung of 4 weeks exposure to the heated tobacco product Ploom TECH+ and 3R4F reference cigarettes.对小鼠肺部的毒性作用进行比较分析,该小鼠连续4周暴露于加热烟草制品Ploom TECH+和3R4F参比卷烟。
J Toxicol Pathol. 2025 Apr;38(2):147-154. doi: 10.1293/tox.2024-0069. Epub 2024 Dec 10.
2
Guidelines for preoperative pulmonary function assessment in patients with lung cancer who will undergo surgery (The Japanese Association for Chest Surgery).拟接受手术的肺癌患者术前肺功能评估指南(日本胸部外科学会)
Gen Thorac Cardiovasc Surg. 2025 Jun;73(6):385-404. doi: 10.1007/s11748-025-02120-7. Epub 2025 Feb 19.
3
Etiology of lung cancer: Evidence from epidemiologic studies.
肺癌的病因:来自流行病学研究的证据。
J Natl Cancer Cent. 2022 Oct 4;2(4):216-225. doi: 10.1016/j.jncc.2022.09.004. eCollection 2022 Dec.
4
Factors Influencing Willingness to Undergo Lung Cancer Screening in the Future: A Cross-Sectional Study of Japanese University Students.影响未来接受肺癌筛查意愿的因素:一项针对日本大学生的横断面研究。
Healthcare (Basel). 2024 Apr 17;12(8):849. doi: 10.3390/healthcare12080849.
5
Surgery for pulmonary lesions in patients with a history of urinary tract transitional cell carcinoma.有尿路移行细胞癌病史患者的肺部病变的外科治疗。
J Cardiothorac Surg. 2024 Mar 12;19(1):117. doi: 10.1186/s13019-024-02607-z.
6
Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study.免疫检查点抑制剂联合铂类药物化疗治疗非小细胞肺癌患者发生免疫相关不良事件的危险因素:一项多中心回顾性研究。
Cancer Immunol Immunother. 2023 Jul;72(7):2169-2178. doi: 10.1007/s00262-023-03408-4. Epub 2023 Feb 27.
7
Effects of Perioperative Oral Management in Patients with Cancer.围手术期口腔管理对癌症患者的影响。
J Clin Med. 2022 Nov 6;11(21):6576. doi: 10.3390/jcm11216576.
8
Response biomarkers of inhalation exposure to cigarette smoke in the mouse lung.小鼠肺部吸入香烟烟雾的反应生物标志物。
J Toxicol Pathol. 2022 Jul;35(3):247-254. doi: 10.1293/tox.2021-0077. Epub 2022 May 21.
9
Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan.仅吸烟年限能否替代吸烟包年数来预测非小细胞肺癌中与吸烟相关的致癌突变风险?日本的一项横断面研究。
BMJ Open. 2020 Sep 9;10(9):e035615. doi: 10.1136/bmjopen-2019-035615.
10
Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next-generation sequencing technique.应用下一代测序技术分析肺多形性癌的靶向性体细胞突变。
Thorac Cancer. 2020 Aug;11(8):2262-2269. doi: 10.1111/1759-7714.13536. Epub 2020 Jun 23.